BLOG

Authentic References

CANOGEM

Gemcitabine Injection IP 200mg/1g

Combination therapy of Gemcitabine & Oxaliplatin has improved Overall Survival, Response
Rate, Time to Progression in patients with pancreatic adenocarcinoma.

British journal of cancer (2006) 94,481-485

CAPIFLO

Capecitabine Tablets IP 500mg

Capecitabine is an effective maintenance treatment in colorectal cancer patients.

U.S. National Library of Medicine, ClinicalTrials.gov (6 jan, 2014)

DOCEFLO

Docetaxel Injection Concentrate IP 20/80/120mg
Enhancement in overall survival & decline in Prostate Specific Antigen serum has achieved with 3 months of Docetaxel treatment in Castration Resistant Prostate Cancer patients.

http://www.transbiomedicine.com 2016

FLOTAXL

Paclitaxel Injection IP 30/100/260mg
Weekly Paclitaxel is an effective & well tolerated treatment for Adjuvant Breast Cancer Patients.

U.S. National Library of Medicine, ClinicalTrials.gov (6 jan, 2014)

FLOPLATIN

Oxaliplatin Injection IP 50mg/100mg
Reintroducing Oxaliplatin is safe & effective for patients with Metastatic Colorectal Cancer who achieved response with prior Oxaliplatin based therapy.

Journal of drug design, developement & therapy. 16 June,2015

BORTZMIB

Bortezomib injection IP 2mg
Bortezomib for the treatment of mentle cell Lymphoma.

Therapeutic Advances in Hematology 2016, Vol. 7(4) 196-208

FLOEPI

Epirubicin Hydrochloride for injection 50mg
Eqirubicin combination regimen has superior effect than other regimen for early breast cancer

The New England Journal of Medicine February 1, 2019

FRACZOL

Zoledronic Acid Injection IP 4mg
Zoledronic acid effectively reduces the frequency of skeletal-related events in patients with bone metastases from wide variety of cancer types.

Therapeutics and Clinical Risk Management 2008:4(1)261-268

LENDOMIDE

Lenalidomide Capsules 10/25mg
Lenalidomide has good efficacy & safety profile than the thalidomide for Myelodysplastic Syndrome treatment.

Therapeutics and Clinical Risk Management 2007:3(4) 553–562

Leave A Comment